Sana Biotechnology logo

Sana Biotechnology Share Price Today

(NASDAQ: SANA)

Sana Biotechnology share price is $1.77 & ₹151.26 as on 26 Apr 2025, 2.30 'hrs' IST

$1.77

Market is closed - opens 7 PM, 28 Apr 2025

View live Sana Biotechnology share price in Dollar and Rupees. Guide to invest in Sana Biotechnology stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Sana Biotechnology, along with analyst recommendations, forecasts, and comprehensive financials.

Sana Biotechnology share price movements

  • Today's Low: $1.65
    Today's High: $1.82

    Day's Volatility :9.35%

  • 52 Weeks Low: $1.26
    52 Weeks High: $10.50

    52 Weeks Volatility :88.0%

Sana Biotechnology (SANA) Returns

PeriodSana Biotechnology IncSector (Health Care)Index (Russel 2000)
3 Months
-47.48%
-4.8%
0.0%
6 Months
-54.85%
-7.5%
0.0%
1 Year
-79.7%
-1.8%
0.0%
3 Years
-75.35%
3.9%
-6.4%

Sana Biotechnology (SANA) Key Statistics

in dollars & INR

Previous Close
$1.77
Open
$1.75
Today's High
$1.82
Today's Low
$1.6499
Market Capitalization
$389.3M
Today's Volume
$1.6M
52 Week High
$10.5
52 Week Low
$1.26
Revenue TTM
$0.0
EBITDA
$-256.0M
Earnings Per Share (EPS)
$-1.15
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-99.17%

How to invest in Sana Biotechnology Stock (SANA) from India?

It is very easy for Indian residents to invest directly in Sana Biotechnology from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Sana Biotechnology stock in both Indian Rupees (INR) and US Dollars (USD). Search for Sana Biotechnology or SANA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Sana Biotechnology or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Sana Biotechnology shares which would translate to 0.483 fractional shares of Sana Biotechnology as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Sana Biotechnology, in just a few clicks!

Returns in Sana Biotechnology (SANA) for Indian investors in Rupees

The Sana Biotechnology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Sana Biotechnology investment value today

Current value as on today

₹23,382

Returns

₹76,618

(-76.62%)

Returns from Sana Biotechnology Stock

₹79,176 (-79.18%)

Dollar Returns

₹2,558 (+2.56%)

Indian investors sentiment towards Sana Biotechnology (SANA)

46%

Period: Mar 26, 2025 to Apr 25, 2025. Change in 30 Days versus previous period

Search interest for Sana Biotechnology Stock from India on INDmoney has increased by 46% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Sana Biotechnology

  • FMR Inc

    14.88%

  • Flagship Ventures Management, Inc.

    11.11%

  • BlackRock Inc

    5.30%

  • Vanguard Group Inc

    4.78%

  • Baillie Gifford & Co Limited.

    4.55%

  • Canada Pension Plan Investment Board

    4.52%

Analyst Recommendation on Sana Biotechnology

Rating
Trend

Buy

    76%Buy

    23%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Sana Biotechnology(by analysts ranked 0 to 5 stars)

Analyst Forecast on Sana Biotechnology Stock (SANA)

What analysts predicted

Upside of 436.72%

Target:

$9.50

Current:

$1.77

Insights on Sana Biotechnology Stock (Ticker Symbol: SANA)

  • Price Movement

    In the last 3 months, SANA stock has moved down by -47.6%
  • SANA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.3% return, outperforming this stock by 149.0%
  • SANA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 56.5% return, outperforming this stock by 132.3%

Sana Biotechnology Technicals Summary

Sell

Neutral

Buy

Sana Biotechnology is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Sana Biotechnology (SANA) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Sana Biotechnology Inc logo
-4.07%
-54.85%
-79.7%
-75.35%
-91.62%
Regeneron Pharmaceuticals, Inc. logo
-5.67%
-35.41%
-32.09%
-10.95%
9.54%
Beone Medicines Ltd logo
-2.45%
17.93%
66.79%
62.33%
55.25%
Vertex Pharmaceuticals Incorporated logo
-2.01%
3.38%
23.9%
84.27%
83.41%
Alnylam Pharmaceuticals, Inc. logo
-10.48%
-15.44%
69.29%
56.6%
70.01%

About Sana Biotechnology

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company's product pipeline consist of UP421, a HIP-modified allogeneic primary islet cell product, which is in phase 1 clinical trial to treat type 1 diabetes; SC451, a HIP-modified, stem cell derived pancreatic islet cell therapy, which is in preclinical trial for the treatment of type 1 diabetes; SC291, a HIP-modified allogeneic CD19-dirtected allogeneic CAR T cell product candidate which is in phase 1 clinical trial to treat systemic lupus erythematosus and ANCA-associated vasculitis, as well as in preclinical trial to treat other indications and b-cell mediated autoimmune disease; and SG299, a CD8-targeted fusosome, which is in preclinical trial to treat patients with hematologic malignancies and B cell mediated autoimmune diseases. It also develops SC262, a hypoimmune-modified CD22-directed allogeneic CAR T program, which is in phase 1 to treat non-Hodgkin's lymphoma; and SG299, a CD8-targeted fusosome, which is in preclinical trial to treat patients with hematologic malignancies and B cell mediated autoimmune diseases. The company has an option and license agreement with Beam Therapeutics Inc. for use of Beam's proprietary CRISPR Cas12b nuclease editing technology to research, develop, and commercialize engineered cell therapy products; and a license agreement with Harvard College to access certain intellectual property for the development of hypoimmune-modified cells. The company was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. Sana Biotechnology, Inc. was incorporated in 2018 and is headquartered in Seattle, Washington.
Organization
Sana Biotechnology
Employees
194
CEO
Dr. Steven D. Harr M.D.
Industry
Services

Management People of Sana Biotechnology

NameTitle
Dr. Steven D. Harr M.D.
President, CEO & Director
Ms. Susan Wyrick
Acting CFO, Treasurer, Principal Accounting Officer and Senior VP of Finance & Accounting
Mr. Snehal Patel
Senior VP & Chief Technical Officer
Dr. Dhavalkumar D. Patel M.D., Ph.D.
Executive VP & Chief Scientific Officer
Mr. Bernard J. Cassidy J.D.
Executive VP, General Counsel & Corporate Secretary
Dr. Sonja Schrepfer M.D., Ph.D.
Senior VP & Head of Hypoimmune Platform
Dr. Gary Meininger M.D.
Chief Medical Officer
Dr. Yuko Soneoka J.D., Ph.D.
Head of Intellectual Property
Mr. John Gerecitano M.D., Ph.D.
Head of Oncology Research & Development

Important FAQs about investing in SANA Stock from India :

What is Sana Biotechnology share price today?

Sana Biotechnology share price today stands at $1.77, Open: $1.75 ; Previous Close: $1.77 ; High: $1.82 ; Low: $1.65 ; 52 Week High: $10.50 ; 52 Week Low: $1.26.

The stock opens at $1.75, after a previous close of $1.77. The stock reached a daily high of $1.82 and a low of $1.65, with a 52-week high of $10.50 and a 52-week low of $1.26.

Can Indians buy Sana Biotechnology shares?

Yes, Indians can invest in the Sana Biotechnology (SANA) from India.

With INDmoney, you can buy Sana Biotechnology at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Sana Biotechnology at zero transaction cost.

How can I buy Sana Biotechnology shares from India?

It is very easy to buy Sana Biotechnology from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Sana Biotechnology (SANA) be purchased?

Yes, you can buy fractional shares of Sana Biotechnology with INDmoney app.

What are the documents required to start investing in Sana Biotechnology stocks?

To start investing in Sana Biotechnology, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Sana Biotechnology Stock (SANA)?

Today’s highest price of Sana Biotechnology (SANA) is $1.82.

Today’s lowest price of Sana Biotechnology (SANA) is $1.65.

What is today's market capitalisation of Sana Biotechnology?

Today's market capitalisation of Sana Biotechnology SANA is 389.3M

What is the 52 Week High and Low Range of Sana Biotechnology Stock (SANA)?

  • 52 Week High

    $10.50

  • 52 Week Low

    $1.26

What are the historical returns of Sana Biotechnology (SANA)?

  • 1 Month Returns

    -4.07%

  • 3 Months Returns

    -54.85%

  • 1 Year Returns

    -79.7%

  • 5 Years Returns

    -91.62%

Who is the Chief Executive Officer (CEO) of Sana Biotechnology ?

Dr. Steven D. Harr M.D. is the current Chief Executive Officer (CEO) of Sana Biotechnology.